These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1691391)

  • 1. Cardiac electrophysiologic effects of a new calcium antagonist, lacidipine.
    Cerbai E; DeBonfioli Cavalcabó P; Masini I; Visentin S; Giotti A; Mugelli A
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):604-9. PubMed ID: 1691391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac electrophysiological effects of a new dihydropyridine calcium antagonist (BBR 2160).
    Barbieri M; Masini I; Porciatti F; Cerbai E; Mugelli A
    Pharmacol Res; 1991 Jan; 23(1):87-94. PubMed ID: 2047363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of CD-349, a dihydropyridine-type calcium antagonist, on goat cardiac Purkinje fibers.
    Tsuchida K; Kaneko K; Aihara H
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):769-76. PubMed ID: 1723775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electropharmacological effects of a new dihydropyridine analog on isolated guinea pig papillary muscles and Purkinje fibers.
    Molyvdas PA; Sperelakis N
    J Cardiovasc Pharmacol; 1986; 8(3):449-58. PubMed ID: 2425157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.
    Carmeliet E
    Eur J Pharmacol; 1980 Feb; 61(3):247-62. PubMed ID: 6767615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac electrophysiologic effects of McN-5691, a new calcium-channel blocking antihypertensive agent.
    Damiano BP; Flaim SF; Gill A; Stump GL; Brannan MD
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):546-56. PubMed ID: 1706795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SR 44866, a potassium channel opener, on action potentials of rabbit, guinea pig, and human heart fibers.
    Gautier P; Bertrand JP; Guiraudou P
    J Cardiovasc Pharmacol; 1991 May; 17(5):692-700. PubMed ID: 1713982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes.
    Cerbai E; Giotti A; Mugelli A
    Br J Pharmacol; 1997 Feb; 120(4):667-75. PubMed ID: 9051306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of oxodipine and nifedipine in the isolated guinea-pig heart.
    Tejerina T; Delgado C; Valenzuela C; Tamargo J
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):186-99. PubMed ID: 3675081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of the new calcium antagonist lacidipine.
    Kawada T; Sun HT; Nakazawa M; Imai S
    Jpn J Pharmacol; 1993 Jul; 62(3):289-96. PubMed ID: 8411776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of lacidipine, a vascular-selective calcium antagonist.
    Micheli D; Ratti E; Toson G; Gaviraghi G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S1-8. PubMed ID: 1725998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP; Stump GL; Yagel SK
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations.
    Raddino R; Metra M; Nodari S; Pelá G; Fappani A; Dei Cas L
    Gen Pharmacol; 1996 Oct; 27(7):1255-9. PubMed ID: 8981077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of several calcium antagonistic drugs on the electrical activity of guinea pig Purkinje fibers.
    Molyvdas PA; Sperelakis N
    Eur J Pharmacol; 1983 Mar; 88(2-3):205-14. PubMed ID: 6852110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac electrophysiologic effects of AHR 5360C.
    Viamonte VM; Hamra M; Rosen MR
    Eur J Pharmacol; 1988 Feb; 146(2-3):215-22. PubMed ID: 3371397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.